{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:51:43Z","timestamp":1789069903323,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04905-y","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T07:39:19Z","timestamp":1756712359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive Network pharmacology and in vitro investigation of L-mimosine: unveiling multi-targeted therapeutic potential against breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jyoti Kumari","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupa","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadfesal","family":"Ghanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurang","family":"sindhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"4905_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.00864","volume":"10","author":"S Nardin","year":"2020","unstructured":"Nardin S, Mora E, Varughese FM, et al. Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Front Oncol. 2020;10:1\u20136. https:\/\/doi.org\/10.3389\/fonc.2020.00864.","journal-title":"Front Oncol"},{"key":"4905_CR2","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Heal. 2020;8:e1027\u201337. https:\/\/doi.org\/10.1016\/S2214-109X(20)30215-1.","journal-title":"Lancet Glob Heal"},{"key":"4905_CR3","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1245\/s10434-022-12151-6","volume":"29","author":"SVS Deo","year":"2022","unstructured":"Deo SVS, Sharma J, Kumar S. GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists. Ann Surg Oncol. 2022;29:6497\u2013500. https:\/\/doi.org\/10.1245\/s10434-022-12151-6.","journal-title":"Ann Surg Oncol"},{"key":"4905_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, Mccormack V, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03502-3.","journal-title":"Nat Med"},{"key":"4905_CR5","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, et al (2022) Chapter 3: Subtypes of Breast Cancer","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"4905_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000321918","volume":"5","author":"C Liedtke","year":"2010","unstructured":"Liedtke C, Schmutzler R, Schneeweiss A, et al. Tripel-negatives Mammakarzinom. Breast Care. 2010;5:359\u201363. https:\/\/doi.org\/10.1159\/000321918.","journal-title":"Breast Care"},{"key":"4905_CR7","doi-asserted-by":"publisher","unstructured":"Zagami P, Carey LA (2022) Triple negative breast cancer: Pitfalls and progress. npj Breast Cancer 8:. https:\/\/doi.org\/10.1038\/s41523-022-00468-0","DOI":"10.1038\/s41523-022-00468-0"},{"key":"4905_CR8","doi-asserted-by":"publisher","unstructured":"Tong CWS, Wu M, Cho WCS, To KKW (2018) Recent advances in the treatment of breast cancer. Front Oncol 8:. https:\/\/doi.org\/10.3389\/fonc.2018.00227","DOI":"10.3389\/fonc.2018.00227"},{"key":"4905_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/0115680096289260240311062343","volume":"24","author":"A Debnath","year":"2024","unstructured":"Debnath A, Mazumder R. Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review. Curr Cancer Drug Targets. 2024;24:555\u201373. https:\/\/doi.org\/10.2174\/0115680096289260240311062343.","journal-title":"Curr Cancer Drug Targets"},{"key":"4905_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox10081291","volume":"10","author":"M Sharma","year":"2021","unstructured":"Sharma M, Dhaliwal I, Rana K, et al. Phytochemistry, pharmacology, and toxicology of datura species\u2014a review. Antioxidants. 2021;10:1\u201312. https:\/\/doi.org\/10.3390\/antiox10081291.","journal-title":"Antioxidants"},{"key":"4905_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2174\/1573406418666220429093956","volume":"18","author":"WR Mir","year":"2022","unstructured":"Mir WR, Bhat BA, Almilaibary A, et al. Evaluation of the In Vitro Antimicrobial Activities of Delphinium roylei: An Insight from Molecular Docking and MD-Simulation Studies. Med Chem (Los Angeles). 2022;18:1109\u201321. https:\/\/doi.org\/10.2174\/1573406418666220429093956.","journal-title":"Med Chem (Los Angeles)"},{"key":"4905_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-025-01384-x","author":"J Kumari","year":"2025","unstructured":"Kumari J, Mohammadfesal Y, Nandan G, et al. Phytonutrients as a Defensive Barrier Against G Ectodomain Fusion in Chandipura Virus Infection. Mol Biotechnol. 2025. https:\/\/doi.org\/10.1007\/s12033-025-01384-x.","journal-title":"Mol Biotechnol"},{"key":"4905_CR13","doi-asserted-by":"publisher","unstructured":"George BP, Chandran R, Abrahamse H (2021) Role of phytochemicals in cancer chemoprevention: Insights. Antioxidants 10:. https:\/\/doi.org\/10.3390\/antiox10091455","DOI":"10.3390\/antiox10091455"},{"key":"4905_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2023.1135898","volume":"14","author":"WR Mir","year":"2023","unstructured":"Mir WR, Bhat BA, Kumar A, et al. Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. Front Pharmacol. 2023;14:1\u201322. https:\/\/doi.org\/10.3389\/fphar.2023.1135898.","journal-title":"Front Pharmacol"},{"key":"4905_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM. Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016;79:629\u201361. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b01055.","journal-title":"J Nat Prod"},{"key":"4905_CR16","doi-asserted-by":"publisher","unstructured":"Mandal AK, Pandey A, Sah RK, et al (2022) In Vitro Antioxidant and Antimicrobial Potency of Mimosa pudica of Nepalese Terai Region: Insight into L-Mimosine as an Antibacterial Agent. Evidence-based Complement Altern Med 2022:. https:\/\/doi.org\/10.1155\/2022\/6790314","DOI":"10.1155\/2022\/6790314"},{"key":"4905_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/1541-4337.12184","volume":"15","author":"G Muhammad","year":"2016","unstructured":"Muhammad G, Hussain MA, Jantan I, Bukhari SNA. Mimosa pudica L., a High-Value Medicinal Plant as a Source of Bioactives for Pharmaceuticals. Compr Rev Food Sci Food Saf. 2016;15:303\u201315. https:\/\/doi.org\/10.1111\/1541-4337.12184.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"4905_CR18","doi-asserted-by":"publisher","unstructured":"Nguyen BCQ, Tawata S (2016) The Chemistry and Biological Activities of Mimosine: A Review. Phyther Res 1230\u20131242. https:\/\/doi.org\/10.1002\/ptr.5636","DOI":"10.1002\/ptr.5636"},{"key":"4905_CR19","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1039\/c9dt04545g","volume":"49","author":"JI Lachowicz","year":"2020","unstructured":"Lachowicz JI, Dalla Torre G, Cappai R, et al. Metal self-assembly mimosine peptides with enhanced antimicrobial activity: Towards a new generation of multitasking chelating agents. Dalt Trans. 2020;49:2862\u201379. https:\/\/doi.org\/10.1039\/c9dt04545g.","journal-title":"Dalt Trans"},{"key":"4905_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389. https:\/\/doi.org\/10.1002\/ijc.33588.","journal-title":"Int J Cancer"},{"key":"4905_CR21","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.3892\/mmr.2018.8403","volume":"17","author":"Y Xu","year":"2018","unstructured":"Xu Y, Cai L. L-mimosine induces caspase-9-mediated apoptosis in human osteosarcoma cells. Mol Med Rep. 2018;17:4695\u2013701. https:\/\/doi.org\/10.3892\/mmr.2018.8403.","journal-title":"Mol Med Rep"},{"key":"4905_CR22","doi-asserted-by":"crossref","unstructured":"Chang H, Lee T, Chuang L, Yen M (1999) Inhibitory effect of mimosine on proliferation of human lung cancer cells is mediated by multiple mechanisms. 145:","DOI":"10.1016\/S0304-3835(99)00209-8"},{"key":"4905_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2014.12.015","volume":"80","author":"LA Pluchino","year":"2015","unstructured":"Pluchino LA, Liu AKY, Wang HCR. Reactive oxygen species-mediated breast cell carcinogenesis enhanced by multiple carcinogens and intervened by dietary ergosterol and mimosine. Free Radic Biol Med. 2015;80:12\u201326. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.12.015.","journal-title":"Free Radic Biol Med"},{"key":"4905_CR24","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1007\/s11030-022-10384-x","volume":"26","author":"A Sharma","year":"2022","unstructured":"Sharma A, Sinha S, Keswani H, Shrivastava N. Kaempferol and Apigenin suppresses the stemness properties of TNBC cells by modulating Sirtuins. Mol Divers. 2022;26:3225\u201340. https:\/\/doi.org\/10.1007\/s11030-022-10384-x.","journal-title":"Mol Divers"},{"key":"4905_CR25","doi-asserted-by":"publisher","unstructured":"Zhang GB, Li QY, Chen QL, Su SB (2013) Network pharmacology: A new approach for Chinese herbal medicine research. Evidence-based Complement Altern Med 2013:. https:\/\/doi.org\/10.1155\/2013\/621423","DOI":"10.1155\/2013\/621423"},{"key":"4905_CR26","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s11030-022-10396-7","volume":"26","author":"A Sharma","year":"2022","unstructured":"Sharma A, Sinha S, Rathaur P, et al. Reckoning apigenin and kaempferol as a potential multi-targeted inhibitor of EGFR\/HER2-MEK pathway of metastatic colorectal cancer identified using rigorous computational workflow. Mol Divers. 2022;26:3337\u201356. https:\/\/doi.org\/10.1007\/s11030-022-10396-7.","journal-title":"Mol Divers"},{"key":"4905_CR27","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","journal-title":"J Med Chem"},{"key":"4905_CR28","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"key":"4905_CR29","doi-asserted-by":"publisher","unstructured":"P Shannon 1, Andrew Markiel 1, Owen Ozier, 2 Nitin S. Baliga, 1 Jonathan T. Wang, 2 Daniel Ramage 2, et al 1971 Cytoscape: A Software Environment for Integrated Models Genome Res 13 426https:\/\/doi.org\/10.1101\/gr.1239303.metabolite","DOI":"10.1101\/gr.1239303.metabolite"},{"key":"4905_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:1\u20137. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11.","journal-title":"BMC Syst Biol"},{"key":"4905_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.stem.2016.07.002","volume":"19","author":"H Zeng","year":"2016","unstructured":"Zeng H, Guo M, Zhou T, et al. An Isogenic Human ESC Platform for Functional Evaluation of Genome-wide-Association-Study-Identified Diabetes Genes and Drug Discovery. Cell Stem Cell. 2016;19:326\u201340. https:\/\/doi.org\/10.1016\/j.stem.2016.07.002.","journal-title":"Cell Stem Cell"},{"key":"4905_CR32","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202\u201313. https:\/\/doi.org\/10.1093\/nar\/gkv951.","journal-title":"Nucleic Acids Res"},{"key":"4905_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, et al. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27:221\u201334. https:\/\/doi.org\/10.1007\/s10822-013-9644-8.","journal-title":"J Comput Aided Mol Des"},{"key":"4905_CR34","doi-asserted-by":"publisher","unstructured":"Shah S, Trivedi P, Ghanchi M, et al (2024) Systems biology approach: identification of hub genes, signaling pathways, and molecular docking of COL1A1 gene in cervical insufficiency. Silico Pharmacol 12:. https:\/\/doi.org\/10.1007\/s40203-024-00218-z","DOI":"10.1007\/s40203-024-00218-z"},{"key":"4905_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","volume":"175","author":"NP Singh","year":"1988","unstructured":"Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184\u201391. https:\/\/doi.org\/10.1016\/0014-4827(88)90265-0.","journal-title":"Exp Cell Res"},{"key":"4905_CR36","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: Highlights of the st gallen international expert consensus on the primary therapy of early breast Cancer 2013. Ann Oncol. 2013;24:2206\u201323. https:\/\/doi.org\/10.1093\/annonc\/mdt303.","journal-title":"Ann Oncol"},{"key":"4905_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41065-023-00300-0","volume":"161","author":"Y Cai","year":"2024","unstructured":"Cai Y, Mei J, Xiao Z, et al. Correction: Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico (Hereditas, (2019), 156, 1, (20), DOI: 10.1186\/s41065-019-0096-6). Hereditas. 2024;161:1\u201312. https:\/\/doi.org\/10.1186\/s41065-023-00300-0.","journal-title":"Hereditas"},{"key":"4905_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12013-014-0459-6","volume":"72","author":"ZQ Tao","year":"2015","unstructured":"Tao ZQ, Shi A, Lu C, et al. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys. 2015;72:333\u20138. https:\/\/doi.org\/10.1007\/s12013-014-0459-6.","journal-title":"Cell Biochem Biophys"},{"key":"4905_CR39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(16)31891-8.","journal-title":"Lancet"},{"key":"4905_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","volume":"24","author":"LA Emens","year":"2018","unstructured":"Emens LA. Breast cancer immunotherapy: Facts and hopes. Clin Cancer Res. 2018;24:511\u201320. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3001.","journal-title":"Clin Cancer Res"},{"key":"4905_CR41","doi-asserted-by":"publisher","unstructured":"Drahansky M, Paridah M., Moradbak A, et al (2016) We are IntechOpen , the world \u2019 s leading publisher of Open Access books Built by scientists , for scientists TOP 1 %. Intech i:13. https:\/\/doi.org\/10.5772\/57353","DOI":"10.5772\/57353"},{"key":"4905_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12026-023-09376-2","volume":"71","author":"H Qayoom","year":"2023","unstructured":"Qayoom H, Sofi S, Mir MA. Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis. Immunol Res. 2023;71:588\u201399. https:\/\/doi.org\/10.1007\/s12026-023-09376-2.","journal-title":"Immunol Res"},{"key":"4905_CR43","doi-asserted-by":"publisher","unstructured":"Dixit N, Motwani H, Patel SK, et al (2023) Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approach. J Biomol Struct Dyn 0:1\u201319. https:\/\/doi.org\/10.1080\/07391102.2023.2256866","DOI":"10.1080\/07391102.2023.2256866"},{"key":"4905_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115576","volume":"423","author":"P Rathaur","year":"2021","unstructured":"Rathaur P, Soni MN, Gelat B, et al. Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer. Toxicol Appl Pharmacol. 2021;423: 115576. https:\/\/doi.org\/10.1016\/j.taap.2021.115576.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4905_CR45","doi-asserted-by":"crossref","unstructured":"El-deeb NM, Ibrahim OM, Kamel AM, et al (2025) Computational development of mushroom- 6-glucan \/ paclitaxel as a synergistic complementary medicine for breast cancer therapy. 7:","DOI":"10.21203\/rs.3.rs-4784256\/v1"},{"key":"4905_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21103526","volume":"21","author":"M Yousuf","year":"2020","unstructured":"Yousuf M, Shamsi A, Khan P, et al. Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int J Mol Sci. 2020;21:1\u201318. https:\/\/doi.org\/10.3390\/ijms21103526.","journal-title":"Int J Mol Sci"},{"key":"4905_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jcb.30176","volume":"123","author":"S Anwar","year":"2022","unstructured":"Anwar S, Khan S, Anjum F, et al. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4. J Cell Biochem. 2022;123:359\u201374. https:\/\/doi.org\/10.1002\/jcb.30176.","journal-title":"J Cell Biochem"},{"key":"4905_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136807","volume":"282","author":"A Debnath","year":"2024","unstructured":"Debnath A, Mazumder R, Singh RK, Singh AK. Discovery of novel CDK4\/6 inhibitors from fungal secondary metabolites. Int J Biol Macromol. 2024;282: 136807. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136807.","journal-title":"Int J Biol Macromol"},{"key":"4905_CR49","doi-asserted-by":"crossref","unstructured":"Debnath A, Mazumder R, Singh AK, Singh RK (2025) Identification of novel cyclin-dependent kinase 4\/6 inhibitors from marine natural products","DOI":"10.1371\/journal.pone.0313830"},{"key":"4905_CR50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejmech.2018.09.030","volume":"159","author":"I Parveen","year":"2018","unstructured":"Parveen I, Khan P, Ali S, et al. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors. Eur J Med Chem. 2018;159:166\u201377. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.030.","journal-title":"Eur J Med Chem"},{"key":"4905_CR51","doi-asserted-by":"crossref","unstructured":"Wadoo R, Ali T, Jan I, et al (2025) In-vitro antioxidant and anti-proliferative activity of aerial parts of Senecio Laetus Edgew on breast cancer ( MCF-7 ) and colon carcinoma","DOI":"10.1186\/s12906-025-04789-y"},{"key":"4905_CR52","doi-asserted-by":"publisher","unstructured":"Olofinsan KA, Abrahamse H, George BP (2025) Anti-proliferative and photodynamic activities of Senna didymobotrya (Fresen.) leaf alkaloid-rich extracts against breast cancer cells. BMC Complement Med Ther 25:17. https:\/\/doi.org\/10.1186\/s12906-025-04763-8","DOI":"10.1186\/s12906-025-04763-8"},{"key":"4905_CR53","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4155\/fmc.12.44","volume":"4","author":"AS Azmi","year":"2012","unstructured":"Azmi AS. Network pharmacology for cancer drug discovery: Are we there yet? Future Med Chem. 2012;4:939\u201341. https:\/\/doi.org\/10.4155\/fmc.12.44.","journal-title":"Future Med Chem"},{"key":"4905_CR54","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.biopha.2018.06.084","volume":"106","author":"P Xu","year":"2018","unstructured":"Xu P, Zhang G, Hou S, Sha L, gui,. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway. Biomed Pharmacother. 2018;106:1419\u201327. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.084.","journal-title":"Biomed Pharmacother"},{"key":"4905_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-022-01596-y","volume":"24","author":"J Luo","year":"2022","unstructured":"Luo J, Zou H, Guo Y, et al. SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Res. 2022;24:1\u201317. https:\/\/doi.org\/10.1186\/s13058-022-01596-y.","journal-title":"Breast Cancer Res"},{"key":"4905_CR56","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1038\/s41388-022-02487-4","volume":"41","author":"SG Pelaz","year":"2022","unstructured":"Pelaz SG, Tabernero A. Src: coordinating metabolism in cancer. Oncogene. 2022;41:4917\u201328. https:\/\/doi.org\/10.1038\/s41388-022-02487-4.","journal-title":"Oncogene"},{"key":"4905_CR57","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00432-011-1049-2","volume":"137","author":"C Zhu","year":"2011","unstructured":"Zhu C, Qi X, Chen Y, et al. PI3K\/Akt and MAPK\/ERK1\/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol. 2011;137:1587\u201394. https:\/\/doi.org\/10.1007\/s00432-011-1049-2.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4905_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.genrep.2017.01.003","volume":"7","author":"AG Thivyah Prabha","year":"2017","unstructured":"Thivyah Prabha AG, Sekar D. Deciphering the molecular signaling pathways in breast cancer pathogenesis and their role in diagnostic and treatment modalities. Gene Reports. 2017;7:1\u201317. https:\/\/doi.org\/10.1016\/j.genrep.2017.01.003.","journal-title":"Gene Reports"},{"key":"4905_CR59","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/onc.2014.153.PRKACA","volume":"34","author":"SE Moody","year":"2015","unstructured":"Moody SE, Schinzel AC, Singh S, et al. HHS Public Access. 2015;34:617\u201332. https:\/\/doi.org\/10.1038\/onc.2014.153.PRKACA.","journal-title":"HHS Public Access"},{"key":"4905_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kong Q, Wang J, et al. Complex roles of cAMP\u2013PKA\u2013CREB signaling in cancer. Exp Hematol Oncol. 2020;9:1\u201313. https:\/\/doi.org\/10.1186\/s40164-020-00191-1.","journal-title":"Exp Hematol Oncol"},{"key":"4905_CR61","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/15548627.2019.1659609","volume":"16","author":"F Yang","year":"2020","unstructured":"Yang F, Xie HY, Yang LF, et al. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells. Autophagy. 2020;16:1061\u201376. https:\/\/doi.org\/10.1080\/15548627.2019.1659609.","journal-title":"Autophagy"},{"key":"4905_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph17101263","volume":"17","author":"OA Al","year":"2024","unstructured":"Al OA, Alasiri G, Alfahed A. Therapeutic, Clinicopathological, and Molecular Correlates of PRKACA Expression in Gastrointestinal Cancers. Pharmaceuticals. 2024;17:1\u201319. https:\/\/doi.org\/10.3390\/ph17101263.","journal-title":"Pharmaceuticals"},{"key":"4905_CR63","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/376599a0","volume":"376","author":"BMT Burgering","year":"1995","unstructured":"Burgering BMT, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995;376:599\u2013602.","journal-title":"Nature"},{"key":"4905_CR64","doi-asserted-by":"publisher","first-page":"30934","DOI":"10.1074\/jbc.M004112200","volume":"275","author":"JI Okano","year":"2000","unstructured":"Okano JI, Gaslightwala I, Birnbaum MJ, et al. Akt\/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J Biol Chem. 2000;275:30934\u201342. https:\/\/doi.org\/10.1074\/jbc.M004112200.","journal-title":"J Biol Chem"},{"key":"4905_CR65","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1158\/0008-5472.CAN-03-3465","volume":"64","author":"JN Hutchinson","year":"2004","unstructured":"Hutchinson JN, Jin J, Cardiff RD, et al. Activation of Akt-1 (PKB-\u03b1) Can Accelerate ErbB-2-Mediated Mammary Tumorigenesis but Suppresses Tumor Invasion. Cancer Res. 2004;64:3171\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3465.","journal-title":"Cancer Res"},{"key":"4905_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.662232","volume":"12","author":"F Martorana","year":"2021","unstructured":"Martorana F, Motta G, Pavone G, et al. AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? Front Pharmacol. 2021;12:1\u201313. https:\/\/doi.org\/10.3389\/fphar.2021.662232.","journal-title":"Front Pharmacol"},{"key":"4905_CR67","unstructured":"Hinz N, J\u00fccker M (2019) 12964_2019_Article_450.pdf. 3:1\u201329"},{"key":"4905_CR68","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.advenzreg.2011.09.020","volume":"52","author":"A Toker","year":"2012","unstructured":"Toker A. Achieving specificity in Akt signaling in cancer. Adv Biol Regul. 2012;52:78\u201387. https:\/\/doi.org\/10.1016\/j.advenzreg.2011.09.020.","journal-title":"Adv Biol Regul"},{"key":"4905_CR69","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/stem.1904","volume":"33","author":"R Gargini","year":"2015","unstructured":"Gargini R, Cerliani JP, Escoll M, et al. Cancer stem cell-like phenotype and survival are coordinately regulated by Akt\/FoxO\/bim pathway. Stem Cells. 2015;33:646\u201360. https:\/\/doi.org\/10.1002\/stem.1904.","journal-title":"Stem Cells"},{"key":"4905_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep44244","volume":"7","author":"M Riggio","year":"2017","unstructured":"Riggio M, Perrone MC, Polo ML, et al. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins. Sci Rep. 2017;7:1\u201312. https:\/\/doi.org\/10.1038\/srep44244.","journal-title":"Sci Rep"},{"key":"4905_CR71","doi-asserted-by":"publisher","unstructured":"Manuscript A (2014) phases of mammary tumor progression. 69:5057\u20135064. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4287.Akt1","DOI":"10.1158\/0008-5472.CAN-08-4287.Akt1"},{"key":"4905_CR72","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1128\/mcb.21.6.2203-2212.2001","volume":"21","author":"J Hutchinson","year":"2001","unstructured":"Hutchinson J, Jin J, Cardiff RD, et al. Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression. Mol Cell Biol. 2001;21:2203\u201312. https:\/\/doi.org\/10.1128\/mcb.21.6.2203-2212.2001.","journal-title":"Mol Cell Biol"},{"key":"4905_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells11152290","volume":"11","author":"B George","year":"2022","unstructured":"George B, Gui B, Raguraman R, et al. AKT1 Transcriptomic Landscape in Breast Cancer Cells. Cells. 2022;11:1\u201321. https:\/\/doi.org\/10.3390\/cells11152290.","journal-title":"Cells"},{"key":"4905_CR74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/1878-0261.13716","volume":"19","author":"J Conde","year":"2024","unstructured":"Conde J, Fern\u00e1ndez-Pisonero I, Lorenzo-Mart\u00edn LF, et al. The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis. Mol Oncol. 2024;19:56\u201380. https:\/\/doi.org\/10.1002\/1878-0261.13716.","journal-title":"Mol Oncol"},{"key":"4905_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102241","volume":"52","author":"L Long","year":"2025","unstructured":"Long L, Wang L, Liang Y, et al. UGCG promotes chemoresistance and breast cancer progression via NF-\u03baB and Wnt\/\u03b2-catenin pathway activation. Transl Oncol. 2025;52: 102241. https:\/\/doi.org\/10.1016\/j.tranon.2024.102241.","journal-title":"Transl Oncol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04905-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:13:12Z","timestamp":1757466792000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04905-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4905"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04905-y","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"318"}}